WORLDCARE CLINICAL COMMENCES DXA AND MRI SERVICES ON NON-ALCOHOLIC FATTY LIVER DISEASE STUDY

WORLDCARE CLINICAL COMMENCES DXA AND MRI SERVICES ON NON-ALCOHOLIC FATTY LIVER DISEASE STUDY

Boston, MA, June 15, 2020 — WorldCare Clinical (WCC) a leading provider of imaging and endpoint assessment committeesfor hepatic clinical trials, today announced that it had commenced MRI and DXA(dual-energy x-ray absorptiometry) services on an international trial to assessa new …

Leave a Reply